According to the National Cancer Institute, approximately 40.5% of Americans will be diagnosed with cancer at some point ...
Formerly believed to predominantly affect Caucasians, new research indicates that MS actually may hit Blacks the hardest.
A promising new treatment accelerates myelin repair, potentially restoring vision and improving brain function in people with ...
The drug could aid in the restoration of vision in those suffering from multiple sclerosis (MS) and other neurodegenerative diseases.
US researchers have found a promising drug candidate that could potentially help repair vision in people with multiple ...
Many of the estimated 1 million people in the U.S. with multiple sclerosis deal with eye and vision problems, as well as ...
Ozanimodâ–¼ is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (RRMS) with active ...
Researchers at the University of Colorado Anschutz Medical Campus have found a promising drug candidate that could help restore vision in individuals with multiple sclerosis (MS) and other ...
The FDA reported that six patients died after being injected with Teva’s Copaxone or Sandoz’s Glatopa. The US Food and Drug ...